Mitigating and learning from the impact of COVID-19 infection on addictive disorders - PubMed (original) (raw)
Editorial
. 2020 Jun;115(6):1007-1010.
doi: 10.1111/add.15080. Epub 2020 Apr 28.
Affiliations
- PMID: 32250482
- PMCID: PMC9364227
- DOI: 10.1111/add.15080
Editorial
Mitigating and learning from the impact of COVID-19 infection on addictive disorders
John Marsden et al. Addiction. 2020 Jun.
Abstract
The COVID-19 pandemic and the measures required to address it are cutting a swathe through people’s lives and the global economy. People with addictive disorders are particularly badly affected as a result of poverty, physical and mental health vulnerabilities and disruption of access to services. The pandemic may well increase the extent and severity of some addictive disorders. Current research is suffering from the termination of face-to-face data collection and other restrictions. There is an urgent need to coordinate efforts nationally and internationally to mitigate these problems and to find innovative ways of continuing to provide clinical and public health services to help people with addictive disorders.
Keywords: Addictive disorders; COVID-19; public health; public health policy; research; treatment.
Comment in
- Response to Marsden et al (2020): Mitigation for the impacts on needle and syringe programmes is needed.
Whitfield M, Reed H, Webster J, Hope V. Whitfield M, et al. Addiction. 2021 Jan;116(1):206-207. doi: 10.1111/add.15193. Epub 2020 Aug 11. Addiction. 2021. PMID: 32696539 No abstract available.
Similar articles
- New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders-The Perfect Storm.
Spagnolo PA, Montemitro C, Leggio L. Spagnolo PA, et al. Am J Psychiatry. 2020 Sep 1;177(9):805-807. doi: 10.1176/appi.ajp.2020.20040417. Epub 2020 Jul 14. Am J Psychiatry. 2020. PMID: 32660296 Free PMC article. No abstract available. - [Transmural addiction care in times of COVID-19 outbreak].
de Cauwer H, Leenders J, Vloemans P, Mondelaers R, Viaene M. de Cauwer H, et al. Tijdschr Psychiatr. 2020;62(5):329-331. Tijdschr Psychiatr. 2020. PMID: 32902834 Dutch. No abstract available. - Mental health and COVID-19: change the conversation.
The Lancet Psychiatry. The Lancet Psychiatry. Lancet Psychiatry. 2020 Jun;7(6):463. doi: 10.1016/S2215-0366(20)30194-2. Epub 2020 May 4. Lancet Psychiatry. 2020. PMID: 32380007 Free PMC article. No abstract available. - Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19.
Koob GF, Powell P, White A. Koob GF, et al. Am J Psychiatry. 2020 Nov 1;177(11):1031-1037. doi: 10.1176/appi.ajp.2020.20091375. Am J Psychiatry. 2020. PMID: 33135468 Review. No abstract available. - COVID-19 and addiction.
Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. Dubey MJ, et al. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):817-823. doi: 10.1016/j.dsx.2020.06.008. Epub 2020 Jun 9. Diabetes Metab Syndr. 2020. PMID: 32540735 Free PMC article. Review.
Cited by
- Changes of Gambling Patterns during COVID-19 in Sweden, and Potential for Preventive Policy Changes. A Second Look Nine Months into the Pandemic.
Håkansson A, Widinghoff C. Håkansson A, et al. Int J Environ Res Public Health. 2021 Feb 27;18(5):2342. doi: 10.3390/ijerph18052342. Int J Environ Res Public Health. 2021. PMID: 33673575 Free PMC article. - Who complies with coronavirus disease 2019 precautions and who does not?
Urbán R, Király O, Demetrovics Z. Urbán R, et al. Curr Opin Psychiatry. 2021 Jul 1;34(4):363-368. doi: 10.1097/YCO.0000000000000723. Curr Opin Psychiatry. 2021. PMID: 34001700 Free PMC article. Review. - Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review.
Mallet J, Dubertret C, Le Strat Y. Mallet J, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070. doi: 10.1016/j.pnpbp.2020.110070. Epub 2020 Aug 12. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32800868 Free PMC article. Review. - Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
Moshkforoush M, DeBeck K, Brar R, Fairbairn N, Cui Z, Milloy MJ, Buxton J, Oldenburger T, McLellan W, Kendall P, Sedgemore K, Wilson D, Kerr T, Hayashi K. Moshkforoush M, et al. Harm Reduct J. 2022 May 25;19(1):50. doi: 10.1186/s12954-022-00632-6. Harm Reduct J. 2022. PMID: 35614440 Free PMC article. - Mental health in the pandemic: a repeated cross-sectional mixed-method study protocol to investigate the mental health impacts of the coronavirus pandemic in the UK.
Van Bortel T, John A, Solomon S, Lombardo C, Crepaz-Keay D, McDaid S, Yap J, Weeks L, Martin S, Guo L, Seymour C, Thorpe L, Morton AD, Davidson G, Kousoulis AA. Van Bortel T, et al. BMJ Open. 2021 Aug 27;11(8):e046422. doi: 10.1136/bmjopen-2020-046422. BMJ Open. 2021. PMID: 34452957 Free PMC article.
References
- Hedegaard H, Warner M, Minino AM. Drug overdose deaths in the United States, 1999–2016. CHS Data Brief, no. 294. Hyattsville, MD: National Center for Health Statistics, 2017; Centers for Disease Control and Prevention. National Vital Statistics System, Mortality; CDC Wonder. Atlanta, GA: US Department of Health and Human Services, CDC; 2017.
- European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2017: Trends and Developments. Luxembourg: Office of the European Union, 2017. Available at: http://www.emcdda.europa.eu/publications/edr/trendsdevelopments/2017 (accessed 4 April 2020).
- Advisory Council on the Misuse of Drugs. Drug-related harms in homeless populations and how they can be reduced. London; 2019. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... (accessed 4 April 2020).
Publication types
MeSH terms
Grants and funding
- R01 AA022328/AA/NIAAA NIH HHS/United States
- R01 AA023657/AA/NIAAA NIH HHS/United States
- R01 AA024930/AA/NIAAA NIH HHS/United States
- MR/S037519/1/MRC_/Medical Research Council/United Kingdom
- UL1 TR001427/TR/NCATS NIH HHS/United States